The DOI matches its Crossref record; 162 of the 165 references it cites were found in a registry or an index.
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Open accessAbstract
Fungal diseases still play a major role in morbidity and mortality in patients with haematological malignancies, including those undergoing haematopoietic stem cell transplantation. Although Aspergillus and other filamentous fungal diseases remain a major concern, Candida infections are still a major cause of mortality. This part of the ESCMID guidelines focuses on this patient population and reviews pertaining to prophylaxis, empirical/pre-emptive and targeted therapy of Candida diseases. Anti-Candida prophylaxis is only recommended for patients receiving allogeneic stem cell transplantation. The authors recognize that the recommendations would have most likely been different if the purpose would have been prevention of all fungal infections (e.g. aspergillosis). In targeted treatment of candidaemia, recommendations for treatment are available for all echinocandins, that is anidulafungin (AI), caspofungin (AI) and micafungin (AI), although a warning for resistance is expressed. Liposomal amphotericin B received a BI recommendation due to higher number of reported adverse events in the trials. Amphotericin B deoxycholate should not be used (DII); and fluconazole was rated CI because of a change in epidemiology in some areas in Europe. Removal of central venous catheters is recommended during candidaemia but if catheter retention is a clinical necessity, treatment with an echinocandin is an option (CII(t) ). In chronic disseminated candidiasis therapy, recommendations are liposomal amphotericin B for 8 weeks (AIII), fluconazole for >3 months or other azoles (BIII). Granulocyte transfusions are only an option in desperate cases of patients with Candida disease and neutropenia (CIII).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [131]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [131]
In the citing paper
“The shift from C. albicans, which is overwhelmingly susceptible to all systemic antifungals, to species that are more frequently resistant or tolerant to fluconazole, such as C. glabrata and C. krusei, has impacted treatment recommendations [11,12,13].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [13]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [5]
In the citing paper
“They display in vitro fungicidal activity against most Candida species, attractive tolerability and pharmacokinetic profiles, and have been recommended as first line agents for invasive candidiasis (1–6).”
From Echinocandin resistance: an emerging clinical problem? (2014) · cites this paper as [5]
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citationKontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Self-citationLiposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Cited by
Sorted by citations
Items 201–300 of 333
Fernández‐Silva, F., Lackner, M., Capilla, J., Mayayo, E., Sutton, D. A., Castanheira, M., Fothergill, A. W., Lass‐Flörl, C., & Guarro, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02666-13 · Cited by 10
Self-citationKnowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients
Colombo, A. L., Agnelli, C., & Kontoyiannis, D. P. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa446 · Cited by 9
Katada, Y., Hira, D., Umemura, K., Katsube, Y., Ishimura, H., Kojima, Y., Hirai, M., Kajiwara, M., Sugimoto, M., Endo, H., et al. (2025) · Clinical and Translational Science · doi:10.1111/cts.70317 · Cited by 8
Mwassi, H. A., Yahav, D., Ayada, G., Matsri, S., Margalit, I., Shargian, L., Bishara, J., & Atamna, A. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106590 · Cited by 8
Rammaert, B., Maunoury, C., Rabeony, T., Corréas, J.-M., Elie, C., Alfandari, S., Berger, P., Rubio, M., Braun, T., Bakouboula, P., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1026067 · Cited by 8
Self-citationSampaio, P., & Pais, C. (2014) · Current Clinical Microbiology Reports · doi:10.1007/s40588-014-0002-y · Cited by 8
Moghnieh, R., El-Rajab, N., Abdallah, D., Fawaz, I., Mugharbil, A., Jisr, T., & Ibrahim, A. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2015.00092 · Cited by 8
Exposure–Response Analysis of Micafungin in Neonatal Candidiasis
Kovanda, L. L., Walsh, T. J., Benjamin, D. K., Arrieta, A. C., Kaufman, D. A., Smith, P. B., Manzoni, P., Desai, A. V., Kaibara, A., Bonate, P. L., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001957 · Cited by 8
Self-citationZhang, R., Chen, J., Huang, H., Ma, J., Meng, F., Tang, Y., Hu, J., Zhang, X., Ji, Y., Ai, H., et al. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2224-2 · Cited by 8
Mistro, S., Rosa, L., Gomes, B., Miranda, L. A. V. D. O., & Badaró, R. J. D. S. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1202766 · Cited by 8
Characterization of Guideline Evidence for Off-label Medication Use in the Intensive Care Unit
Shoulders, B. R., Smithburger, P. L., Tchen, S., Buckley, M. S., Lat, I., & Kane‐Gill, S. L. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017699635 · Cited by 8
Sandoval‐Denis, M., Pastor, F. J., Capilla, J., Sutton, D. A., Fothergill, A. W., & Guarro, J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.024 · Cited by 7
Ao, W., Klonoski, J. M., Berlinghoff, E., Jensen, J., Afroz, T., Munns, D., Lindsey, W., Denys, G. A., & JENISON, R. D. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00982-17 · Cited by 7
Zhou, L., Li, M., Li, H., Guo, Z., Gao, Y., Zhang, H., Qin, F., Sang, Z., Xing, Q., Cheng, L., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1157944 · Cited by 7
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection
Sanchis, M., Guarro, J., Sutton, D. A., Fothergill, A. W., Wiederhold, N. P., & Capilla, J. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.09.010 · Cited by 7
Rammaert, B., Candon, S., Maunoury, C., Bougnoux, M., Jouvion, G., Braun, T., Corréas, J.-M., & Lortholary, O. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12637 · Cited by 7
Self-citationFilamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
Viñado, C., Girón, R. M., Ibáñez, E., García‐Ortega, A., Pérez, I., Polanco, D., Pemán, J., & Solé, A. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.03.005 · Cited by 7
Assessment of high-priced systemic antifungal prescriptions
Poulat, C., Nivoix, Y., Launoy, A., Lutun, P., Bachellier, P., Rohr, S., Woehl, M.-L., Levêque, D., Letscher‐Bru, V., Herbrecht, R., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.03.004 · Cited by 7
Self-citationGangneux, J., Cheikh, J. E., Herbrecht, R., Yakoub‐Agha, I., Quiniou, J.-B., Caillot, D., & Michallet, M. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0203-4 · Cited by 7
Self-citationKlyasova, G. A., Malchikova, A. O., Tandilova, K. S., Блохина, Е. В., Parovichnikova, E. N., Кравченко, С. К., & Vg, S. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.08.000385 · Cited by 7
Major, A., Paje, D. G., Taxbro, K., McQuilten, Z., Kin, A. D., Alexandrou, E., Hsaiky, L. M., Hill, J. G., Moss, J. G., Kamboj, M., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02523 · Cited by 6
Evaluation of the Eazyplex® Candida ID LAMP Assay for the Rapid Diagnosis of Positive Blood Cultures
Berlau, A., Stoll, S., Edel, B., Löffler, B., & Rödel, J. (2024) · Diagnostics · doi:10.3390/diagnostics14192125 · Cited by 6
Maquera-Afaray, J., Cuellar, L. E., Cornely, O. A., Salmanton‐García, J., IFI Diagnostic and Treatment Capacity Collaborator Team Peru, Reategui, A. M., Flores, A. M. D., Sabogal, A. C., Pinedo, A. M. R., Candia, A. G. E., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02020-24 · Cited by 6
Self-citationvan Engen, A., Casamayor, M., Kim, S., Watt, M., & Odeyemi, I. A. O. (2017) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s141548 · Cited by 6
Diagnostic and clinical management of Candida auris infections in immunocompromised patients
Posteraro, B., Cosio, T., Torelli, R., Carolis, E. D., Magrì, C., Posteraro, P., Angelis, G. D., & Sanguinetti, M. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2505567 · Cited by 7
Désoubeaux, G., Franck-Martel, C., Bailly, É., Brun, C. L., Gyan, E., Goudeau, A., Chandenier, J., & Lanotte, P. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.08.013 · Cited by 5
Infektionen bei Patient*innen mit Akuter Myeloischer Leukämie
Ehrlich, S., Spiekermann, K., Grothe, J. H., & Stemler, J. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1873-4858 · Cited by 5
Sanchis, M., Capilla, J., Castanheira, M., Martín‐Vicente, A., Sutton, D. A., Fothergill, A. W., Wiederhold, N. P., & Guarro, J. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.12.020 · Cited by 5
In vitro interactions of crocin with fluconazole against Candida isolates
Aslani, N., Hedayati, M. T., Nabili, M., Faramarzi, A., Sadeghi, F., & Moazeni, M. (2019) · Current Medical Mycology · doi:10.18502/cmm.4.4.383 · Cited by 5
Kaddour, F. O., Aissaoui, N., Dib, M. E. A., Bensaid, O., & Muselli, A. (2020) · The Natural Products Journal · doi:10.2174/2210315510666200110154053 · Cited by 5
Maurille, C., Bonhomme, J., Briant, A. R., Parienti, J., Verdon, R., & Fournier, A. L. (2022) · Journal of Fungi · doi:10.3390/jof8050541 · Cited by 5
Zhu, X., Zhang, W., Zhang, Y., Wang, Y., Hu, H., Li, J., Zhou, Y., Han, T., & Huang, D. (2023) · Hematology · doi:10.1080/16078454.2023.2172292 · Cited by 5
Chronic infections of the small intestine
Bourke, B., & Hussey, S. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000153 · Cited by 5
Seyedmousavi, S., İlkit, M., Durdu, M., Ergin, Ç., Polat, S. H., Melchers, W. J. G., & Verweij, P. E. (2015) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2015.001 · Cited by 5
Self-citationSalas, V., Pastor, F. J., Capilla, J., Sutton, D. A., Mayayo, E., Fothergill, A. W., Rinaldi, M. G., & Guarro, J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.05.011 · Cited by 4
Chen, Z., Zhen, S., Sun, J., Zhou, L., Zhang, T., Shen, Y., Guo, W., Zheng, Y., Zhang, F., Mi, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-97004-4 · Cited by 4
Current Epidemiology and Management of Invasive Candidiasis in Infants
Zimmerman, K. O., & Smith, P. B. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0167-5 · Cited by 4
Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?
Gedık, H., Şimşek, F., Yıldırmak, T., Kantürk, A., Arica, D. A., Aydın, D., Demirel, N., & Yokuş, O. (2014) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-014-0370-8 · Cited by 4
Cesaro, S., Tridello, G., Knelange, N. S., Blijlevens, N. M. A., Martin, M., Snowden, J. A., Malladi, R. K., Ljungman, P. T., Deconinck, É., Gedde‐Dahl, T., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01212-1 · Cited by 4
Veselov, A. V., Vasilyeva, N. V., Богомолова, Т. С., Рудольфовна, Р. Е., Kutsevalova, O. Y., Нижегородцева, И. А., Петрова, Л. В., Shmidt, N. V., Moskvitina, E. N., Витальевна, С. М., et al. (2018) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2018.1.49-54 · Cited by 4
Sakamoto, Y., Isono, H., Enoki, Y., Taguchi, K., Miyazaki, T., Kunimoto, H., Koike, H., Hagihara, M., Matsumoto, K., Nakajima, H., et al. (2021) · Journal of Fungi · doi:10.3390/jof7110975 · Cited by 4
Recent trends in the development of bacterial and fungal vaccines
Mir, M. A., Usman, M., Qadri, H., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00003-6 · Cited by 4
Arnould, J.-S., & Floch, R. L. (2015) · PubMed Central · Cited by 4
Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 4
Zhang, R., Chen, J., Huang, H., Ma, J., Meng, F., Tang, Y., Hu, J., Zhang, X., Ji, Y., Ai, H., et al. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2269-2 · Cited by 4
Seyedmousavi, S. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc295 · Cited by 4
Giesen, N., Mellinghoff, S. C., Khatamzas, E., Korell, F., Hentrich, M., Einsele, H., Henze, L., Heußel, C., Hohmann, C., Jensen, B.-E. O., et al. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06769-9 · Cited by 3
Self-citationInfektionen bei hämatoonkologischen Patienten auf der Intensivstation
Kochanek, M., von Bergwelt‐Baildon, M., & Shimabukuro‐Vornhagen, A. (2013) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-012-0179-x · Cited by 3
Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps
Kourti, M., & Roilides, E. (2024) · Mycopathologia · doi:10.1007/s11046-024-00896-5 · Cited by 3
Self-citationYang, Y., Yi, Q.-Y., Han, Y., Li, Y., & Yang, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-79512-x · Cited by 3
Lass‐Flörl, C. (2025) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2025.05.002 · Cited by 3
Self-citationBilal, H., Li, X., Wang, X., Khan, M. N., Shafiq, M., Yu, J., Qiu, H., Lv, Q., & Xu, B. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1630226 · Cited by 3
Paredes, K., Pastor, F. J., Capilla, J., Sutton, D. A., Mayayo, E., Fothergill, A. W., & Guarro, J. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.10.008 · Cited by 3
Mareș, M., Minea, B., Năstasă, V., Roșca, I., Bostănaru, A.-C., Marincu, I., Toma, V., Cristea, V. C., Murariu, C., & Pinteală, M. (2017) · Medical Mycology · doi:10.1093/mmy/myx059 · Cited by 3
Candida auris – emerging fungal pathogen
Grondalska, D., & Kmieciak, W. (2017) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2017.56.3.282 · Cited by 3
Enfermedades invasoras por hongos levaduriformes en pacientes neutropénicos
Ruíz-Camps, I., & Jarque, I. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.11.001 · Cited by 3
Yahata, S., Kenzaka, T., Kushida, S., Nishisaki, H., & Akita, H. (2017) · International Medical Case Reports Journal · doi:10.2147/imcrj.s119787 · Cited by 3
Antifungal agents use in a French administrative region
Fattah, M. A., Demoré, B., Girardeau, A., Heit, S., May, T., Rabaud, C., & Hénard, S. (2015) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2015.04.010 · Cited by 3
Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
Villaescusa, T., Vázquez, L., Bergua, J., García, J., Romero, A., Olave, M. T., Belmonte, D. G., & Llano, M. P. Q. D. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/067.2019 · Cited by 3
Uribe, B., González, O., Ourliac‐Garnier, I., Pape, P. L., Ba, B. B., Alonso, R. M., & Gaudin, K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113366 · Cited by 3
Combined Effect of Platelets and Anidulafungin against Aspergillus fumigatus Infections
Schiefermeier Mach, N., Bellmann, R., Fréalle, É., & Perkhofer, S. (2017) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000334 · Cited by 2
Negru, G., Kamus, L., Bîcu, E., Shova, S. G., Sendid, B., Dubar, F., & Ghinet, A. (2021) · Molecules · doi:10.3390/molecules26195861 · Cited by 2
Bienvenu, A., Leray, V., Guichon, C., Bourget, S., Chapuis, C., Dureault, A., Pavèse, P., Roux, S., Kahale, E., Chaabane, W., et al. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2023.11.002 · Cited by 2
Bienvenu, A., Cour, M., Pavèse, P., Guichon, C., Leray, V., Chapuis, C., Dureault, A., Mohkam, K., Gallet, S., Bourget, S., et al. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae118 · Cited by 2
Fungal infections—Background to specific fungal species
Sokóvić, M., & Λιάρας, Κ. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815824-1.00002-0 · Cited by 2
Recent Studies on Invasive Fungal Diseases in Children and Adolescents: an Update
Nieves, D. J., & Arrieta, A. C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0172-8 · Cited by 2
Alanio, A. (2013) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.04.001 · Cited by 2
Factors influencing recovery in patients with hemoblastoses and candidemia
Klyasova, G. A., Блохина, Е. В., Gracheva, A., Кравченко, С. К., Parovichnikova, E. N., Александрович, О. В., Korobova, A. G., Galstyan, G. M., & Kulikov, S. M. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587777-87 · Cited by 2
Dong, W., Zhang, G. Z., Li, J. X., Wang, Y., Wang, T. T., & Dong, Y. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12570 · Cited by 2
Intensive Care Practice in the Cancer Patient Population: Special Considerations and Challenges
Darvall, J. N., Byrne, T., Douglas, N. W. R., & Anstey, J. R. (2018) · Current anesthesiology reports · doi:10.1007/s40140-018-0293-2 · Cited by 2
Guidelines for antifungal therapies in intensive care unit patients: not so bad!
Boyer, A., Cadier, G., Accoceberry, I., Lhomme, É., Ricard, C., Gruson, D., & Blanchard, É. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.05.009 · Cited by 2
Case 31-2020: A 48-Year-Old Man with Lymphoma and Abdominal Pain
Mansour, M. K., Smibert, O. C., Kambadakone, A. R., & Sfeir, M. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmcpc1904039 · Cited by 2
Fungaemia and disseminated infection
Lester, R., & Rex, J. H. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0025 · Cited by 2
Chronic Infections of the Small Intestine
Bourke, B., & Hussey, S. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch63 · Cited by 2
Can Prolonged Incubation of Negative Blood Cultures Show Fungal Positivity?
Sığ, A. K., Yıldırım, D. Ö., Serin, B. G., & Güney, M. (2023) · Balıkesır Health Sciences Journal · doi:10.53424/balikesirsbd.1205875 · Cited by 1
Kara, E., Sahin, N., Yumrucu, F. G., & Metan, G. (2026) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-026-02149-5 · Cited by 1
Gillissen, A., & Paparoupa, M. (2017) · Pneumo News · doi:10.1007/s15033-017-0668-y · Cited by 1
The Role of Biomarkers for Starting Antifungals in the Intensive Care Unit
Pagani, J., Revelly, J., Que, Y., & Eggimann, P. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000118 · Cited by 1
Ferrer, R., de la Cámara, A. G., Ramos, I. J., Quindós, G., & Tejerina, M. T. (2013) · Actualidad en farmacología y terapéutica · Cited by 1
Michallet, M., Cheikh, J. E., Herbrecht, R., Yakoub‐Agha, I., Caillot, D., & Gangneux, J. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07216-6 · Cited by 1
Self-citationAtalay, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-06088-6_9 · Cited by 1
Candidosen als Folge einer Chemotherapie
Nenoff, P. (2014) · hautnah dermatologie · doi:10.1007/s15012-014-1762-z · Cited by 1
Interventions for the management of esophageal candidiasis in immunocompromised patients
Ōnishi, A., Iwasaku, M., Sato, A., & Furukawa, T. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011938 · Cited by 1
Belotserkovskiy, B. Z., Гельфанд, Е. Б., Bykov, A. O., Mamontova, O. A., & Николаевич, П. Д. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-4-11-20 · Cited by 1
Some issues of the resistance of Candida glabrata to echinocandins
Veselov, A. V. (2019) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2019.4.324-329 · Cited by 1
Cherkasova, E., Semiglazova, Т. Y., Филатова, Л. В., & Загоруйко, В. А. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-3-28(403)-40-46 · Cited by 1
Hepato-splenic candidiasis confirmed following splenectomy: a case report
Peinoit, A., Cousin, É., Escoffre‐Barbe, M., Bernard, M., Bénézit, F., & Lamy, T. (2021) · Infezioni in Medicina · doi:10.53854/liim-2904-17 · Cited by 1
Cottom, L., & McPhee, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00133-x · Cited by 1
Antifungal treatment guidelines
Cottom, L., & Jones, B. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0049 · Cited by 1
Management of Invasive Fungal Infections after Hematopoietic Stem Cell Transplantation
Asano‐Mori, Y. (2015) · Journal of Hematopoietic Cell Transplantation · doi:10.7889/hct.4.91
In Vitro Screening of Antifungal Compounds Able to Counteract Biofilm Development
Girardot, M., & Imbert, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0467-9_13
Frühzeitig und konsequent behandeln
Nenoff, P. (2013) · Uro-News · doi:10.1007/s00092-013-0260-7
Micafungin Review of its Use in the Prophylaxis and Treatment of
Bassetti, M., Fisher, B. T., Groll, A. H., Kalin, M., Lomaestro, B. M., & Rogers, T. R. (2012)
Self-citationAntiinfektiöse Therapieprinzipien bei akuten Leukämien
von Lilienfeld‐Toal, M. (2017) · Der Onkologe · doi:10.1007/s00761-017-0223-9
Infections after Hematopoietic Cell Transplantation: Progress?
Abutalib, S. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.017
Current and potential treatment options for invasiveCandidainfections
Pyrpasopoulou, A., Iosifidis, Ε., & Roilides, E. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1379392
Self-citationAkut myeloid lösemi hastasında kronik dissemine kandidiyazisin başarılı tedavisi
Öztürk, E., Soyer, N., Bayraktaroglu, S., Hekimgil, M., Töbü, M., & Arda, B. (2014) · Ege Tıp Dergisi · doi:10.19161/etd.344093
Rodríguez-Leguizamón, G. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.48713/10336_13785
Wu, A. Y.-J., Tseng, H.-K., & Liu, C.-P. (2018) · 內科學誌 · doi:10.6314/jimt.201802_29(1).05
Metadata
- Authors
- Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., Cornely, O. A., Donnelly, J. P., Garbino, J., Groll, A. H., Hope, W. W., Jensen, H. E., Kullberg, B. J., Lass-Flörl, C., Lortholary, O., Meersseman, W., Petrikkos, G., Richardson, M. D., Roilides, E., Verweij, P. E., & Cuenca-Estrella, M.
- Affiliations
- University of Würzburg (DE)
- Hacettepe University (TR)
- Hôpital d'Hautepierre (FR)
- University of Genoa (IT)
- Statens Serum Institut (DK)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Centre Hospitalier Universitaire Vaudois (CH)
- Istituto Giannina Gaslini (IT)
- University of Cologne (DE)
- Radboud University Medical Center (NL)
- University Hospital of Geneva (CH)
- University Hospital Münster (DE)
- University of Liverpool (GB)
- University of Copenhagen (DK)
- Hôpital Necker-Enfants Malades (FR)
- Universitair Ziekenhuis Leuven (BE)
- National and Kapodistrian University of Athens (GR)
- Manchester Academic Health Science Centre (GB)
- Aristotle University of Thessaloniki (GR)
- Corresponding author
- Ullmann, A.J.
- ORCID
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 18
- Pages
- 53-67
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2037123829
- Cited by
- 334
- References
- 165
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 13 · 2023: 19 · 2022: 17 · 2021: 24 · 2020: 19 · 2019: 23 · 2018: 34 · 2017: 43 · 2016: 24 · 2015: 37 · 2014: 34 · 2013: 24 · 2012: 2
- FWCI
- 21.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Microbiology and Infection (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CS/08/08/10)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidiasis, candidemia, chronic disseminated candidiasis, hematologic malignancies, hematopoietic stem cell transplantation, antifungal prophylaxis, echinocandins, anidulafungin, caspofungin, micafungin, liposomal amphotericin B, fluconazole, central venous catheter removal, granulocyte transfusion, neutropenia, antifungal resistance
- MeSH terms
- Adult, Antifungal Agents, Candidiasis, Catheterization, Central Venous, Humans, Neutropenia, Hematopoietic Stem Cell Transplantation, Evidence-Based Medicine, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
